House panel calls to ban China data from FDA drug trial applications
A powerful spending committee in Congress wants the FDA to ban the use of clinical trial data from China in future applications by drugmakers to test new treatments. The language was
Rep. Andy Harris (R-MD) (Michael Brochstein/Sipa USA/Sipa via AP Images) April 30, 2026 02:28 PM EDT ChinaFDA+ House panel calls for banning China data from FDA drug trial applications Max Bayer Senior Reporter A powerful spending committee in Congress wants the FDA to ban the use of clinical trial data from China in future applications by drugmakers to … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that